Q Wang, YY Wang, WJ Pu, X Ma,
RJ Ni - Journal of Anatomy, 2023 - Wiley Online Library
Abstract Pexidartinib (PLX3397), a colony‐stimulating factor‐1 receptor (CSF1R) inhibitor, is
currently in phase 1–3 clinical trials as a treatment for a variety of tumours. CSF1R signalling …